deniskatz
The Architectural Shift in Depression
How Brain Network Topology Is Reframing CNS Strategy By Denis Katz, MD, MHAFounder, Salience Clinical From Chemistry to Systems For much of its modern history, psychiatry has approached major depressive disorder (MDD) through the lens of neurochemistry primarily as dysregulation of serotonin, norepinephrine, and dopamine. This paradigm enabled important therapeutic advances, but its impact has […]